Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
29 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

General


RSS FeedsuniQure Announces 36 Weeks of Follow-Up Data from Phase IIb Study of AMT-061 and Long-Term Follow-Up Data for AMT-060 in Patients with Hemophilia B
(WorldNews Netherlands)

 
 

6 july 2019 17:20:50

 
uniQure Announces 36 Weeks of Follow-Up Data from Phase IIb Study of AMT-061 and Long-Term Follow-Up Data for AMT-060 in Patients with Hemophilia B
(WorldNews Netherlands)
 


~ FIX Activity Up to 54% of Normal, with Mean of 45% of Normal, at 36 Weeks After Administration of AMT-061 in Phase IIb Study ~ ~ Clinical Benefit and Tolerability of AMT-060 Maintained in All Patients Through up to 3.5 Years of Follow-up ~ LEXINGTON, Mass. and AMSTERDAM, the Netherlands, July 06, 2019 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced updated clinical data on the three patients treated in the Company`s ongoing Phase IIb study of AMT-061, an investigational AAV5 -based gene therapy containing a patent-protected FIX-Padua variant for the treatment of...


 
11 viewsCategory: General > Europe > Netherlands
 
Netherlands defeat Sweden; to meet US in WWC final
(WorldNews Netherlands)
Flying Dutch take remarkable rise to the final frontier against USA
(WorldNews Netherlands)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten